Get the Stockscreener App
0.4474
6.50%
-0.0311
Ispecimen Inc stock is traded at $0.4474, with a volume of 1.69M.
It is down -6.50% in the last 24 hours and down -29.54% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
See More
Previous Close:
$0.4785
Open:
$0.4821
24h Volume:
1.69M
Relative Volume:
0.87
Market Cap:
$4.37M
Revenue:
$10.39M
Net Income/Loss:
$-9.52M
P/E Ratio:
-0.0234
EPS:
-19.12
Net Cash Flow:
$-6.02M
1W Performance:
-7.42%
1M Performance:
-29.54%
6M Performance:
-60.41%
1Y Performance:
-87.03%
1-Day Range:
$0.4291
$0.4822
1-Week Range:
$0.4291
$0.5299
52-Week Range:
$0.3869
$4.32
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
0.4474 | 4.68M | 10.39M | -9.52M | -6.02M | -19.12 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Ispecimen Inc Stock (ISPC) Latest News
Volatility Watch: Can iSpecimen Inc stock hit record highs againEarnings Miss & Smart Investment Allocation Insights - moha.gov.vn
Is iSpecimen Inc a good long term investmentQuarterly Earnings Review & Daily Tips From Top Market Analysts - earlytimes.in
iSpecimen (ISPC) Stock Price, Quote, News & History - Benzinga
Would You Still Hold iSpecimen Stock If It Fell Another 30%? - Trefis
Is iSpecimen Inc. stock supported by strong fundamentalsWeekly Trend Summary & Comprehensive Market Scan Insights - Newser
Downgrade Watch: Will iSpecimen Inc stock split attract more investorsShare Buyback & Consistent Return Investment Signals - moha.gov.vn
Will iSpecimen Inc. stock split attract more investors2025 Investor Takeaways & AI Enhanced Trading Signals - Newser
How iSpecimen Inc. stock responds to policy changesQuarterly Trade Summary & Fast Moving Stock Watchlists - Newser
iSpecimen Regains Nasdaq Compliance as of November 2025 - The Globe and Mail
Is iSpecimen Stock Built to Withstand More Downside? - Trefis
iSpecimen Inc. Regains Nasdaq Compliance - TradingView
iSpecimen Inc (ISPC) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
How iSpecimen Inc. stock performs after earningsTrade Exit Report & Technical Entry and Exit Tips - BỘ NỘI VỤ
LifeMD (NASDAQ:LFMD) vs. iSpecimen (NASDAQ:ISPC) Financial Review - Defense World
A look into iSpecimen Inc (ISPC)’s deeper side - Setenews
iSpecimen Faces Nasdaq Delisting Notice for Stock Price - MSN
LifeMD (NASDAQ:LFMD) and iSpecimen (NASDAQ:ISPC) Head to Head Contrast - Defense World
iSpecimen receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Nigeria
iSpecimen Inc. (ISPC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
iSpecimen receives Nasdaq notice for minimum bid price deficiency - Investing.com
[DEF 14A] iSpecimen Inc. Definitive Proxy Statement - Stock Titan
[8-K] iSpecimen Inc. Reports Material Event | ISPC SEC FilingForm 8-K - Stock Titan
How iSpecimen Inc. stock reacts to inflationary pressuresOptions Play & Free Expert Verified Stock Movement Alerts - newser.com
Can iSpecimen Inc. stock maintain growth trajectory2025 Price Action Summary & Safe Entry Trade Reports - newser.com
Will iSpecimen Inc. stock maintain momentum in 2025Portfolio Return Report & Community Trade Idea Sharing - newser.com
[Form 3] iSpecimen Inc. Initial Statement of Beneficial Ownership - Stock Titan
Will iSpecimen Inc. stock deliver consistent dividendsMarket Risk Analysis & Long-Term Safe Investment Plans - newser.com
What does recent volatility data suggest for iSpecimen Inc.July 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
How buybacks impact iSpecimen Inc. stock valueSell Signal & Technical Analysis for Trade Confirmation - newser.com
Predicting iSpecimen Inc. trend using moving averagesOil Prices & Risk Managed Investment Signals - newser.com
ISpecimen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] iSpecimen Inc. Quarterly Earnings Report | ISPC SEC FilingForm 10-Q - Stock Titan
iSpecimen Inc. stock momentum explainedMarket Risk Report & Safe Entry Momentum Tips - newser.com
Why iSpecimen Inc. stock could see breakout soonStop Loss & Weekly High Return Opportunities - newser.com
Published on: 2025-11-15 14:05:23 - newser.com
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):